| 1. |
Haller JA, Dugel P, Weinberg DV, et al. Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema[J]. Retina, 2009, 29(1): 46-51. DOI: 10.1097/IAE.0b013e318188c814.
|
| 2. |
Boyer DS, Yoon YH, Belfort R Jr, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema[J]. Ophthalmology, 2014, 121(10): 1904-1914. DOI: 10.1016/j.ophtha.2014.04.024.
|
| 3. |
Haller JA, Bandello F, Belfort R Jr, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion[J]. Ophthalmology, 2010, 117(6): 1134-1146. DOI: 10.1016/j.ophtha.2010.03.032.
|
| 4. |
Cicinelli MV, Gerosolima C, Scandale P, et al. Clinical and imaging biomarkers of response to intravitreal dexamethasone implant in eyes with non-infectious uveitic macular oedema[J]. Eye (Lond), 2024, 38(5): 910-916. DOI: 10.1038/s41433-023-02802-7.
|
| 5. |
Khurana RN, Appa SN, McCannel CA, et al. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies[J]. Ophthalmology, 2014, 121(1): 67-71. DOI: 10.1016/j.ophtha.2013.06.033.
|
| 6. |
Zafar A, Aslanides IM, Selimis V, et al. Uneventful anterior migration of intravitreal ozurdex implant in a patient with iris-sutured intraocular lens and descemet stripping automated endothelial keratoplasty[J]. Case Rep Ophthalmol, 2018, 9(1): 143-148. DOI: 10.1159/000486924.
|
| 7. |
吳頔, 任新軍, 李筱榮. 地塞米松玻璃體腔植入劑異位于前房一例[J]. 中華眼底病雜志, 2019, 35(6): 607-608. DOI: 10.3760/cma.j. issn.1005-1015.2019.06.019. DOI: 10.3760/cma.j.issn.1005-1015.2019.06.019.Wu D, Ren XJ, Li XR. Dexamethasone vitreous cavity implant was located in the anterior chamber in one case[J]. Chin J Ocul Fundus Dis, 2019, 35(6): 607-608. DOI: 10.3760/cma.j.issn.1005-1015. 2019.06.019. DOI: 10.3760/cma.j.issn.1005-1015.2019.06.019.
|
| 8. |
Rahimy E, Pitcher JD 3rd, Abbey AM, et al. No-touch removal of anterior segment-migrated dexamethasone implant[J]. Retina, 2015, 35(11): 2414-2416. DOI: 10.1097/IAE.0000000000000753.
|
| 9. |
Stavrakas P, Gartaganis P, Totou S, et al. Anterior chamber dislocation of dexamethasone implant in the presence of carlevale sutureless scleral fixation intraocular lens[J]. Case Rep Ophthalmol, 2023, 14(1): 229-233. DOI: 10.1159/000529790.
|
| 10. |
梁玲玲, 鞠勝, 崔治華. 地塞米松玻璃體腔植入劑異位于前房自行復位1例[J]. 中華眼科雜志, 2024, 60(3): 272-274. DOI: 10.3760/cma.j.cn112142-20231025-00181.Liang LL, Ju S, Cui ZH. Dislocation into the anterior chamber and spontaneous repositioning of a dexamethasone intravitreal implant: a case report[J]. Chin J Ophthalmol, 2024, 60(3): 272-274. DOI: 10.3760/cma.j.cn112142-20231025-00181.
|
| 11. |
宋爽, 谷瀟雅, 張晉榮, 等. 地塞米松眼內植入劑異位于前房1例[J]. 中華眼底病雜志, 2024, 40(9): 720-721. DOI: 10.3760/cma.j.cn511434-20240409-00149.Song S, Gu XY, Zhang JR, et al. One case of dexamethasone intraocular implant located in the anterior chamber[J]. Chin J Ocul Fundus Dis, 2024, 40(9): 720-721. DOI: 10.3760/cma.j.cn511434-20240409-00149.
|
| 12. |
Tsoutsanis P, Kapantais D. Anterior migration of Ozurdex implant: a review on risk factors, complications, and management[J/OL]. Int J Retina Vitreous, 2023, 9(1): 74[2023-11-27]. https://pubmed.ncbi.nlm.nih.gov/38012689/. DOI: 10.1186/s40942-023-00513-5.
|
| 13. |
Tsoutsanis P , Kapantais D. Anterior migration of Ozurdex implant: a review on risk factors, complications, and management[J/OL]. Int J Retina Vitreous, 2023, 9(1): 74[2023-11-27]. https://pubmed.ncbi.nlm.nih.gov/38012689/. DOI: 10.1186/s40942-023-00513-5.
|
| 14. |
R?ck D, Bartz-Schmidt KU, R?ck T. Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration[J/OL]. BMC Ophthalmol, 2019, 19(1): 120[2019-05-28]. https://pubmed.ncbi.nlm.nih.gov/31138164/. DOI: 10.1186/s12886-019-1122-1.
|
| 15. |
Kang H, Lee MW, Byeon SH, et al. The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex?)[J]. Graefe’s Arch Clin Exp Ophthalmol, 2017, 255(9): 1819-1825. DOI: 10.1007/s00417-017-3705-y.
|
